Department of Surgery, University of California, San Francisco, CA 94143-0790, USA.
Surgery. 2013 Apr;153(4):473-80. doi: 10.1016/j.surg.2012.08.068. Epub 2012 Dec 4.
Unlike new drugs and medical devices, most surgical procedures are developed outside clinical trials and without regulatory oversight. Surgical professional organizations have discussed how new procedures should be introduced into practice without agreement on what topics informed consent discussions must include. To provide surgeons with more specific guidance, we wanted to determine what information patients and surgeons consider essential to disclose before an innovative surgical procedure.
Of those approached, 85 of 113 attending surgeons and 383 of 541 adult postoperative patients completed surveys; responses to the surveys were 75% and 71%, respectively. Using a 6-point Likert scale, participants rated the importance of discussing 16 types of information preoperatively for 3 techniques (standard open, laparoscopic, robotic) offered for a hypothetic partial hepatectomy.
Compared with surgeons, patients placed more importance on nearly all types of information, particularly volumes and outcomes. For all 3 techniques, approximately 80% of patients indicated that they could not decide on surgery without being told whether it would be the surgeon's first time doing the procedure. When considering an innovative robotic surgery, a clear majority of both patients and surgeons agreed that it was essential to disclose the novel nature of the procedure, potentially unknown risks and benefits, and whether it would be the surgeon's first time performing the procedure.
To promote informed decision-making and autonomy among patients considering innovative surgery, surgeons should disclose the novel nature of the procedure, potentially unknown risks and benefits, and whether the surgeon would be performing the procedure for the first time. When accurate volumes and outcomes data are available, surgeons should also discuss these with patients.
与新药和医疗器械不同,大多数外科手术都是在临床试验之外开发的,没有监管监督。外科专业组织已经讨论了新程序应该如何引入实践,但对于知情同意讨论必须包括哪些主题仍未达成一致意见。为了为外科医生提供更具体的指导,我们想确定患者和外科医生在进行创新手术前认为必须披露哪些信息。
在受邀的人员中,有 113 名主治外科医生中的 85 名和 541 名成年术后患者中的 383 名完成了调查;对调查的答复率分别为 75%和 71%。参与者使用 6 点李克特量表对 3 种技术(标准开放、腹腔镜、机器人)提供的假设部分肝切除术进行了 16 种类型信息的术前讨论重要性进行评分。
与外科医生相比,患者几乎对所有类型的信息都更加重视,尤其是手术量和结果。对于所有 3 种技术,大约 80%的患者表示,如果没有被告知手术是否为外科医生首次进行,他们将无法决定是否进行手术。在考虑创新的机器人手术时,大多数患者和外科医生都认为必须披露手术的新颖性、潜在的未知风险和益处,以及这是否是外科医生首次进行该手术。
为了促进考虑创新手术的患者的知情决策和自主权,外科医生应披露手术的新颖性、潜在的未知风险和益处,以及外科医生是否将首次进行该手术。当有准确的手术量和结果数据时,外科医生也应该与患者讨论这些数据。